What is LakeShore Biopharma Co Ltd (LSB)?

LakeShore Biopharma Co Ltd（LSB）の株式分析

$0.627

-0.130 (-20.68%)終値時点

Loading chart…

High: 0.850
Open: 0.790
VWAP: 0.68
Vol: 942.22K
Mkt Cap: —
Low: 0.574
Amount: 644.26K
EV/EBITDA, TTM: 5.50

LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.

www.ysbiopharm.com

バリュエーション指標

The current forward P/E ratio for LakeShore Biopharma Co Ltd (LSB) is 2.02, compared to its 5-year average forward P/E of -1.22.

Forward P/E

Strongly Overvalued

5Y Average P/E

-1.22

Current P/E

2.02

割高

0.38

割安

-2.82

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-31.03

Current EV/EBITDA

5.50

割高

13.91

割安

-75.98

Forward P/S

Fair

5Y Average P/S

0.55

Current P/S

0.17

割高

1.11

割安

-0.01

イベントタイムライン

2025-09-12 (ET)